Bausch Health
BHC
#3335
Rank
$3.19 B
Marketcap
$8.71
Share price
1.04%
Change (1 day)
18.18%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$2.66

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$2.66. In 2022 the company made an earnings per share (EPS) of -$0.62 an increase over its 2021 EPS that were of -$2.66.

EPS history for Bausch Health from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.66327.91%
2022-$0.62-76.64%
2021-$2.6668.45%
2020-$1.58-68.91%
2019-$5.07-57.11%
2018-$11.83-272.22%
2017$6.87-199.29%
2016-$6.92798.7%
2015-$0.77-128.31%
2014$2.72-204.62%
2013-$2.60602.7%
2012-$0.37-171.15%
2011$0.52-143.96%
2010-$1.18-206.57%
2009$1.11-11.2%
2008$1.252.46%
2007$1.22-7.58%
2006$1.32-14.29%
2005$1.5454%
2004$1.00-500%
2003-$0.25-141.67%
2002$0.60-4.76%
2001$0.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.27-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.00-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA